NasdaqGS:ACADBiotechs
A Fresh Leadership Perspective: Assessing Acadia Pharmaceuticals (ACAD) Valuation After Key Strategy Appointment
A leadership shakeup can often set the stage for a company’s next chapter, and that appears to be happening at ACADIA Pharmaceuticals (ACAD). On August 25, the company announced the appointment of Konstantina Katcheves as Senior Vice President, Chief Business and Strategy Officer. With a resume featuring significant deals and experience at industry leaders like Teva Pharmaceuticals and Bristol Myers Squibb, Katcheves will lead business development and corporate strategy at ACADIA. This move...